Corporate Updates

GE Healthcare compensates $30 million to resolve medicare fraud case

The US Justice Department articulated that General Electric Co. (GE)s health-care unit will give in excess of 30 million dollars to resolve claims that a company it bought in 2004 given false information to Medicare to pad billings for a drug used to diagnose heart disease.
The deception settlement declared on Jan. 29 linking the drug Myoview sold by Amersham Health Incorporation resolves claims filed in the False Claims Act. The act permits whistle-blowers to follow fraud claims on behalf of the federal government and then share in any recovery.


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top